TARU PUBLICATIONS
Journal of Information and Optimization Sciences cover
Hybrid ·Peer-reviewed·ISSN (Online): 2169-0103·ISSN (Print): 0252-2667

WoS  JIF 2026 : 0.4 (Q4)

Powered by:Powered by

Monthly Journal: Publishes theoretical and applied research on topics in information and optimization sciences.

Issues up to 2022 co-published with and available at:Taylor & Francis
submissions@tarupublications.com
Open Access Research Article

The prevalence of hypomagnesaemia among college students and its significant association with high BMI

* , , , , , , , , ,

* Corresponding author · click or hover a name for details

pp. 329–344Vol. 46Issue 2March 2025DOI: 10.47974/JIOS-1918XML
Received:
13 Nov 2024
Published Online:
17 Mar 2025
Article type:
Research Article
Language:
EN
Article no.:
JIOS-1918
Pages:
329–344

Abstract

This study intends to explore the widespread nature of hypomagnesaemia among college students at Jazan University and test possible link with some anthropometric attributes like their ages, height, weight & body mass index (BMI). A total of 134 student volunteers had participated in this study aged between 18 and 24 years. The research was carried out at college of applied medical sciences at Jazan University, Jazan province, southern-west Saudi Arabia, between November 2023 and January 2024. Blood sample were collected from all participants and subjected to serum magnesium analysis based on a colorimetric method. The frequency of hypomagnesaemia cases were 18 (13.4%) and hypermagnesemia was 6 (4.5%). Serum magnesium level showed a statistically significant negative correlational relationship with BMI (Pearson’s coefficient r=-0.201; p-value= 0.019). Furthermore, obese subjects (BMI>30) showed lower levels of serum magnesium compared to normal BMI category (BMI=18-25) that was statistically significant; p-value=0.0023. The research provides the prevalence of hypomagnesaemia in college student’s population. The study also reported a direct link between obesity and low serum magnesium levels. Additional analysis with a greater sample size is required to support these discoveries.

Keywords

Subject Classifications

Primary11H60Secondary 26A24

References

[1] A. M. Al Alawi, S. W. Majoni, and H. Falhammar, “Magnesium and human health: Perspectives and research directions,” Int. J. Endocrinol., vol. 2018, p. 9041694, Apr. (2018), doi: 10.1155/2018/9041694.
[2] S. L. Volpe, “Magnesium in disease prevention and overall health,” Adv. Nutr., vol. 5, no. 6, pp. 1–9 (2014).
[3] D. Fiorentini, C. Cappadone, G. Farruggia, and C. Prata, “Magnesium: Biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency,” Nutrients, vol. 13, no. 4, p. 1136, Mar. (2021), doi: 10.3390/nu13041136.
[4] A. Srivastava, B. Gupta, C. Gupta, and P. Shukla, “Emerging functions of hypermagnesemia in cellular physiology with a special reference to excitable cells,” J. Biol. Chem., vol. 291, no. 23, pp. 10573–10579 (2016).
[5] W. Jahnen-Dechent and M. Ketteler, “Magnesium basics,” Clin. Kidney J., vol. 5, Suppl. 1, pp. i3–i14, Feb. (2012), doi: 10.1093/ndtplus/sfr163.
[6] C. Supakatisant and V. Phupong, “Oral magnesium for relief in pregnancy-induced leg cramps: A randomized controlled trial,” J. Clin. Psychopharmacol., vol. 32, no. 3, pp. 311–315 (2012).
[7] A. E. Kirkland, G. L. Sarlo, and K. F. Holton, “The role of magnesium in neurological disorders,” Nutrients, vol. 10, no. 6, p. 730, Jun. (2018), doi: 10.3390/nu10060730.
[8] A. Peikert, C. Wilimzig, and R. Köhne-Volland, “Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double-blind randomized study,” Cephalalgia, vol. 16, no. 4, pp. 257–263 (1996).
[9] S. Castiglioni, A. Cazzaniga, W. Albisetti, and J. A. Maier, “Magnesium and osteoporosis: Current state of knowledge and future research directions,” Nutrients, vol. 5, no. 8, pp. 3022–3033, Jul. (2013), doi: 10.3390/nu5083022.
[10] T.S. Orchard, M. J. A. Thomas, C. A. Ristow, M. L. Bauer, J. L. Hough, D. C. Larkins, and D. S. M. Winters, “Magnesium intake, bone mineral density, and fractures: Results from the Women’s Health Initiative Observational Study,” Am. J. Clin. Nutr., vol. 99, no. 4, pp. 926–933 (2014).
[11] M. S. Razzaque, “Magnesium: Are we consuming enough? ,” Nutrients, vol. 10, no. 12, p. 1863, Dec. (2018), doi: 10.3390/nu10121863.
[12] V. Bhatnagar, R. S. Sharma, A. K. Gupta, S. P. S. Yadav, and P. K. Verma, “Descriptive analysis of COVID-19 patients in the context of India,” J. Interdiscip. Math., vol. 24, no. 3, pp. 489–504 (2021).
[13] U. Gröber, “Magnesium and drugs,” Int. J. Mol. Sci., vol. 20, no. 9, p. 2094, Apr. (2019), doi: 10.3390/ijms20092094.
[14] A. Rosanoff, C. M. Weaver, and R. K. Rude, “Suboptimal magnesium status in the United States: Are the health consequences underestimated?,” Nutr. Rev., vol. 70, no. 3, pp. 153–164 (2012).
[15] L.C. Del Gobbo, M. J. A. Thomas, C. A. Ristow, M. L. Bauer, J. L. Hough, D. C. Larkins, and D. S. M. Winters, “Magnesium intake and cardiovascular disease risk,” Circulation, vol. 127, no. 1, pp. 33–45 (2013).
[16] G. Saini, R. S. Sharma, A. K. Gupta, S. P. S. Yadav, and P. K. Verma, “Structural equation-based model to investigate the moderating effect of fear of COVID using partial least square method,” J. Interdiscip. Math., vol. 25, no. 3, pp. 703–720 (2022).
[17] T.S. Orchard, M. J. A. Thomas, C. A. Ristow, M. L. Bauer, J. L. Hough, D. C. Larkins, and D. S. M. Winters, “Magnesium intake, bone mineral density, and fractures: Results from the Women’s Health Initiative Observational Study,” Am. J. Clin. Nutr., vol. 99, no. 4, pp. 926–933 (2014).
[18] S. R. Garrison, G. M. Allan, R. K. Sekhon, and V. M. Musini, “Magnesium for skeletal muscle cramps,” Cochrane Database Syst. Rev., vol. 4 (2014).
[19] J.H. Huang, X. L. Zhang, Y. L. Li, L. M. Chen, W. F. Li, and Z. X. Wang, “Correlations of magnesium intake with metabolic parameters, depression, and physical activity in elderly type 2 diabetes patients: A cross-sectional study,” Nutr. J., vol. 12, no. 1, p. 1 (2013).
[20] E. K. Tarleton, B. Littenberg, and C. D. MacLean, “Role of magnesium supplementation in the treatment of depression: A randomized clinical trial,” PLoS One, vol. 12, no. 6, p. e0180067 (2017).
[21] K. Upreti, S. R. Joshi, A. P. Sharma, P. K. Verma, and R. M. Singh, “Deep dive into diabetic retinopathy identification: A deep learning approach with blood vessel segmentation and lesion detection,” J. Mobile Multimedia, vol. 20, pp. 495–524 (2024), doi: 10.13052/jmm1550-4646.20210.
[22] A.V. Agarwal, N. Verma, S. Saha, and S. Kumar, “Dynamic detection and prevention of denial of service and peer attacks with IP address processing,” Recent Findings in Intelligent Computing Techniques: Proceedings of the 5th ICACNI 2017, Volume 1, pp. 707–139 (2018).
[23] M. A. Beydoun, T. L. Gary, B. H. Caballero, R. S. Lawrence, and L. J. Cheskin, “Association of magnesium intake with metabolic syndrome, insulin resistance, and systemic inflammation in the National Health and Nutrition Examination Survey (NHANES) 2001–2006,” Diabetes Care, vol. 31, no. 11, pp. 235–240 (2008).
[24] N. E. Saris, E. Mervaala, H. Karppanen, and J. A. Khawaja, “Magnesium: An update on physiological, clinical and analytical aspects,” Clinica Chimica Acta, vol. 294, no. 1–2, pp. 1–26 (2000).
[25] N. Rosique-Esteban, M. Guasch-Ferré, P. Hernández-Alonso, J. Salas-Salvadó, and D. Corella, “Dietary magnesium and cardiovascular disease: A review with emphasis in epidemiological studies,” Nutrients, vol. 10, no. 2, p. 168 (2018).
[26] L. E. Simental-Mendía, M. Rodríguez-Morán, and F. Guerrero-Romero, “The role of magnesium in type 2 diabetes: A brief based-clinical review,” Magnesium Research, vol. 30, no. 2, pp. 54–59 (2017).
[27] M.K. Gupta, R. S. Sharma, P. K. Verma, A. R. Yadav, and S. P. S. Yadav,  “Detection and localization for watermarking technique using LSB encryption for DICOM Image,” J. Discrete Math. Sci. Cryptogr., vol. 25, no. 1, pp. 193–204 (2022).
[28] N. Rosique-Esteban, M. Guasch-Ferré, P. Hernández-Alonso, J. Salas-Salvadó, and D. Corella, “Dietary magnesium and cardiovascular disease: A review with emphasis in epidemiological studies,” Nutrients, vol. 10, no. 2, p. 168 (2018).
[29] Y. Song, Y. Zhang, L. Wang, M. L. Liu, and H. L. Li, “Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: A meta-analysis of randomized double-blind controlled trials,” Diabetic Medicine, vol. 35, no. 4, pp. 430–438 (2018).
[30] N.A. Althumiri, M. H. Alharthi, R. M. Alenzi, and S. S. Alzahrani, “Obesity in Saudi Arabia in 2020: Prevalence, distribution, and its current association with various health conditions,” Healthcare (Basel), vol. 9, no. 3, p. 311, Mar. (2021), doi: 10.3390/healthcare9030311.
[31] Z.A. Memish, M. S. Al-Hamdan, F. A. Al-Qattan, and A. M. El-Sayed,  “Obesity and associated factors—Kingdom of Saudi Arabia, 2013,” Preventing Chronic Disease, vol. 11, p. E174, 2014.
[32] S. Alsulami, A. S. Alghamdi, M. A. Almarshad, and A. F. Almefleh, “Obesity prevalence, physical activity, and dietary practices among adults in Saudi Arabia,” Front. Public Health, vol. 11, p. 1124051, Mar. (2023), doi: 10.3389/fpubh.2023.1124051.
[33] H. M. Al-Hazzaa, “Prevalence of physical inactivity in Saudi Arabia: A brief review,” East. Mediterr. Health J., vol. 17, no. 4, pp. 335–343 (2011).
[34] E. S. Ford and A. H. Mokdad, “Dietary magnesium intake in a national sample of US adults,” J. Nutr., vol. 133, no. 9, pp. 2879–2882 (2017).
[35] Y. Song, Y. Zhang, L. Wang, M. L. Liu, and H. L. Li, “Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: A meta-analysis of randomized double-blind controlled trials,” Diabetic Medicine, vol. 23, no. 10, pp. 1050–1056 (2019).
[36] K. Yamashita, M. Kawai, K. Sekine, T. Tominaga, and T. Yokoi, “Relationship between dietary magnesium intake and metabolic syndrome risk factors among middle-aged and elderly Japanese subjects,” J. Nutr. Sci. Vitaminol., vol. 57, no. 3, pp. 197–203 (2016).
[37] S. Li, B. Guo, W. Chen, W. Wang, and Y. Shen, “The association between serum magnesium levels and obesity in China,” Medicine, vol. 96, no. 52, p. e9066 (2018).
[38] A. M. Alquaiz, A. Kazi, R. Qureshi, and A. R. Siddiqui, “Prevalence and factors associated with low bone mineral density in Saudi women: A community-based survey,” BMC Musculoskelet. Disord., vol. 14, p. 102 (2013).
[39] K. Upreti, S. R. Joshi, A. P. Sharma, P. K. Verma, and R. M. Singh, “A multi-model unified disease diagnosis framework for cyber healthcare using IoMT-cloud computing networks,” J. Discrete Math. Sci. Cryptogr., vol. 26, no. 6, pp. 1819–1834 (2023), doi: 10.47974/JDMSC-1831.
[40] A.B. Kanwade, M.P. Sardey, S.A. Panwar, P.K. Verma, and R. M. Singh,  “Combined weighted feature extraction and deep learning approach for chronic obstructive pulmonary disease classification using electromyography,” Int. J. Inf. Technol. (2023), doi: 10.1007/s41870-023-01498-y.
[41] A. Viswas, P.K. Dabla, S. Gupta, S. R. Sharma, and M. L. Bauer, “SCN1A genetic alterations and oxidative stress in idiopathic generalized epilepsy patients: A causative analysis in refractory cases,” Indian J. Clin. Biochem. (2023), doi: 10.1007/s12291-023-01164-x.
[42] N.A. Kannan, M. S. Al-Hamdan, F. A. Al-Qattan, and A. M. El-Sayed,  “Future perspectives on new innovative technologies comparison against hybrid renewable energy systems,” Comput. Electr. Eng., vol. 111, p. 108910 (2023), doi: 10.1016/j.compeleceng.2023.108910.
[43] P.K. Dabla, M. A. Almarshad, R. S. Sharma, and A. F. Almefleh, “Target association rule mining to explore novel paediatric illness patterns in emergency settings,” Scand. J. Clin. Lab. Investig., vol. 82, no. 7–8, pp. 595–600 (2022), doi: 10.1080/00365513.2022.2148121.

Views: 281Downloads: 72Citations: 0